These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8914464)

  • 41. Activated protein C resistance in a neonate with venous thrombosis.
    Kodish E; Potter C; Kirschbaum NE; Foster PA
    J Pediatr; 1995 Oct; 127(4):645-8. PubMed ID: 7562293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resistance to activate protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons.
    Dahlbäck B
    Thromb Haemost; 1995 May; 73(5):739-42. PubMed ID: 7482395
    [No Abstract]   [Full Text] [Related]  

  • 43. Changes of resistance to activated protein C in the course of pregnancy and prevalence of factor V mutation.
    Mimuro S; Lahoud R; Beutler L; Trudinger B
    Aust N Z J Obstet Gynaecol; 1998 May; 38(2):200-4. PubMed ID: 9653861
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
    Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
    Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mortality and causes of death in families with the factor V Leiden mutation (resistance to activated protein C).
    Hille ET; Westendorp RG; Vandenbroucke JP; Rosendaal FR
    Blood; 1997 Mar; 89(6):1963-7. PubMed ID: 9058717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
    Dahlbäck B
    Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis.
    Zöller B; Dahlbäck B
    Lancet; 1994 Jun; 343(8912):1536-8. PubMed ID: 7911873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of lupus anticoagulant on a commercially available kit for APC-resistance.
    Halbmayer WM; Haushofer A; Schön R; Fischer M
    Thromb Haemost; 1994 Oct; 72(4):645-6. PubMed ID: 7878647
    [No Abstract]   [Full Text] [Related]  

  • 49. Resistance to activated protein C and a novel factor V gene mutation.
    Voelkerding KV
    Clin Lab Med; 1996 Mar; 16(1):169-86. PubMed ID: 8867589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activated protein c resistance (APC) and inherited factor V (FV) mis-sense mutation in patients with venous and arterial thrombosis in a haematology clinic.
    Ma DD; Aboud MR; Williams BG; Isbister JP
    Aust N Z J Med; 1995 Apr; 25(2):151-4. PubMed ID: 7605298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis.
    Bertina RM; Reitsma PH; Rosendaal FR; Vandenbroucke JP
    Thromb Haemost; 1995 Jul; 74(1):449-53. PubMed ID: 8578504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Laboratory diagnosis of resistance to activated protein C (APC-resistance).
    Bertina RM
    Thromb Haemost; 1997 Jul; 78(1):478-82. PubMed ID: 9198200
    [No Abstract]   [Full Text] [Related]  

  • 53. Modified test for activated protein C resistance.
    Jorquera JI; Montoro JM; Fernández MA; Aznar JA; Aznar J
    Lancet; 1994 Oct; 344(8930):1162-3. PubMed ID: 7864945
    [No Abstract]   [Full Text] [Related]  

  • 54. Factor V Leiden and thrombophilia.
    Simioni P; Scudeller A; Girolami A
    N Engl J Med; 1995 May; 332(20):1382. PubMed ID: 7715653
    [No Abstract]   [Full Text] [Related]  

  • 55. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
    Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A
    Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activated-protein-C resistance in cancer patients.
    Green D; Maliekel K; Sushko E; Akhtar R; Soff GA
    Haemostasis; 1997; 27(3):112-8. PubMed ID: 9306127
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of an activated partial thromboplastin time with a Russell viper venom time test in screening for factor V(Leiden) (FVR506Q).
    Sweeney JD; Blair AJ; King TC
    Am J Clin Pathol; 1997 Jul; 108(1):74-7. PubMed ID: 9208981
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Upper mesenteric venous thrombosis revealing familial resistance to activated protein C].
    Grimaud L; Defuentes G; Duvic C; Leveque C; Brinquin L
    Presse Med; 2003 Oct; 32(32):1505-6. PubMed ID: 14534468
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factor V Leiden: is it the chief contributor to activated protein C resistance in Asian-Indian patients with deep vein thrombosis?
    Biswas A; Bajaj J; Ranjan R; Meena A; Akhter MS; Yadav BK; Sharma V; Saxena R
    Clin Chim Acta; 2008 Jun; 392(1-2):21-4. PubMed ID: 18342013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular detection of a common mutation in coagulation factor V causing thrombosis via hereditary resistance to activated protein C.
    Liu XY; Nelson D; Grant C; Morthland V; Goodnight SH; Press RD
    Diagn Mol Pathol; 1995 Sep; 4(3):191-7. PubMed ID: 7493138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.